BlackRock’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,612
| Closed | -$1.01K | – | 5519 |
|
|
2023
Q2 | $1.01K | Hold |
4,612
| – | – | ﹤0.01% | 5318 |
|
|
2023
Q1 | $1.45K | Sell |
4,612
-12,651
| -73% | -$3.98K | ﹤0.01% | 5369 |
|
|
2022
Q4 | $20.4K | Sell |
17,263
-185
| -1% | -$218 | ﹤0.01% | 5292 |
|
|
2022
Q3 | $16K | Sell |
17,448
-287
| -2% | -$263 | ﹤0.01% | 5459 |
|
|
2022
Q2 | $20K | Sell |
17,735
-18,091
| -50% | -$20.4K | ﹤0.01% | 5467 |
|
|
2022
Q1 | $63K | Sell |
35,826
-7,375
| -17% | -$13K | ﹤0.01% | 5293 |
|
|
2021
Q4 | $101K | Buy |
43,201
+974
| +2% | +$2.28K | ﹤0.01% | 5198 |
|
|
2021
Q3 | $156K | Buy |
42,227
+10,614
| +34% | +$39.2K | ﹤0.01% | 4973 |
|
|
2021
Q2 | $234K | Buy |
31,613
+5,232
| +20% | +$38.7K | ﹤0.01% | 4801 |
|
|
2021
Q1 | $156K | Buy |
26,381
+2,702
| +11% | +$16K | ﹤0.01% | 4713 |
|
|
2020
Q4 | $144K | Buy |
23,679
+1,079
| +5% | +$6.56K | ﹤0.01% | 4448 |
|
|
2020
Q3 | $160K | Buy |
22,600
+2,972
| +15% | +$21K | ﹤0.01% | 4340 |
|
|
2020
Q2 | $131K | Buy |
19,628
+13,343
| +212% | +$89.1K | ﹤0.01% | 4359 |
|
|
2020
Q1 | $36K | Buy |
6,285
+570
| +10% | +$3.27K | ﹤0.01% | 4457 |
|
|
2019
Q4 | $25K | Buy |
5,715
+4,493
| +368% | +$19.7K | ﹤0.01% | 4567 |
|
|
2019
Q3 | $8K | Hold |
1,222
| – | – | ﹤0.01% | 4688 |
|
|
2019
Q2 | $12K | Buy |
+1,222
| New | +$12K | ﹤0.01% | 4695 |
|